Planisware SAS (PLNW)
Vienna Exchange · Austria · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 27.90 |
|---|---|
| 52-week range | 13.80 – 27.90 |
| Return, 1 month / 3 months | +14.6% / +38.1% |
| Return, 1 year / 3 years | +33.1% / – |
| Trend | Uptrend |
| RSI (14) | 77 |
| Volatility (1 year) | 42.9% |
| Worst drawdown (1 year) | -40.9% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Planisware is a French software company based in Paris that provides enterprise project and portfolio management software. Its platform helps organisations plan, prioritise and track projects, manage resources and budgets, and coordinate product development and research activities. Customers are typically large organisations in industries such as manufacturing, aerospace, automotive, energy, pharmaceuticals and public services that need to oversee many complex projects at once. The software is delivered as a subscription service and can also be deployed on the customer's own systems.
On this site Planisware SAS appears as a stock on the Vienna Exchange (Austria), code PLNW, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Planisware SAS (PLNW) trades on the Vienna Exchange in Austria. It last closed at EUR 27.90 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 43 of 84 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.1% and over the last three months it rose 38.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Vienna Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 96 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 39.8% | ||
| From 52-week high | 0.0% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 38.1% | ||
| 6-month return | 54.1% | ||
| 12-month return, skipping the last month | 16.1% | ||
| Stability (higher is calmer) | 24 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.9% | ||
| Liquidity | 5 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 96.7% | ||
| Income | 14 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +7.3% |
|---|---|
| 1 month | +14.6% |
| 3 months | +38.1% |
| 6 months | +54.1% |
| 1 year | +33.1% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 24.72 / 19.96 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jun 2026 | EUR 0.3600 |
| 24 Jun 2025 | EUR 0.3100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Vienna Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.